RxDoctor Payments Data

Penny Taggart

Psychiatric/Mental Health · Pass Christian, MSNPI 1326748740

Payments from drug & device makers

$925in general payments, 2019–2025

Across 55 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$696
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$122
  • Lundbeck LLC$39
  • Corium, LLC$38
  • Axsome Therapeutics, Inc.$30

What the payments were for

  • Food & beverage$88796%
  • Education$394%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$925 in reported general payments places this provider in the 55th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$17,209
Medicare patients
81
Services billed
214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl44$59,294
TrintellixVortioxetine Hydrobromide16$8,174
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine94$2,376
Trazodone Hcl58$958
Duloxetine Hcl22$404
Venlafaxine Hcl ErVenlafaxine Hcl31$285
Quetiapine Fumarate27$276
Aripiprazole14$247
Divalproex Sodium11$212
Bupropion XlBupropion Hcl26$212
Buspirone Hcl36$197
Olanzapine11$192
Bupropion Hcl SrBupropion Hcl22$186
Lamotrigine24$184
Clonazepam74$178

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$696$59,29444 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Pass Christian

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →